We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stock Research Reports for Pfizer, Microsft & Bank of America
Read MoreHide Full Article
Wednesday, December 21 2016
Today's Research Daily features new research reports on 16 major stocks, including Pfizer (PFE - Free Report) , Microsoft (MSFT - Free Report) and Bank of America (BAC - Free Report) .
Pfizer shares have gained +9.5% since results of the presidential election were declared on Nov 8, outperforming the Zacks Large-Cap Pharma industry which has gained +1.7% over the same period. While Pfizer in general and the industry as a whole continues to be weighed down by drug pricing worries, the issue has eased a bit since the election. The analyst emphasizes that Pfizer is strengthening its product portfolio as well as pipeline through acquisitions and licensing deals. A case in point is the Sep 2016 acquisition of Medivation that has strengthened Pfizer’s cancer franchise. Meanwhile, new products like Ibrance should do well and drive revenues. However, headwinds remain in the form of genericization, pricing pressure and rising competition, which will continue to hamper top-line growth. (You can read the full research report on Pfizer here>>>)
Buy rated Microsoft shares lagged the Zacks Tech sector through the fall, but have led the way over the last three months on greater appreciation for the company's reorganization and repositioning. Microsoft's 'cloud' opportunity particularly stands out, with the company generally considered as a leader in this fast-growing space alongside Amazon, Google and others. The Zacks analyst points to the company's continuing enterprise strength, benefits from the Office 365 subscription model, strong growth prospects of Azure and promising new products. Further, the anticipated completion of the LinkedIn acquisition will boost Microsoft's presence in the social media market. (You can read the full research report on Microsoft here>>>)
Buy rated Bank of America shares have been one of the biggest beneficiaries of the changed macro backdrop following the election. This changed backdrop includes expectations of faster economic growth and overhaul of the country's tax and regulatory systems. The resulting uptrend in interest rates promises to give bank stocks in general and Bank of America in particular a big boost. No doubt, Bank of America share have been strong performers since the election - up +33.6% since November 8th vs. +21.8% gain for the Zacks Major Banks industry in that time period. (You can read the full research report on Bank of America here>>>)
Free Access: All Zacks Research Reports Starting today, you are invited to download in-depth analysis reports covering more than 1,000 of the most widely followed stocks. Valued at $25 each, they are yours to consult over the next 30 days absolutely free. They feature sensitive Zacks Rank information on each stock that you won't find anywhere else. See the reports free >>
Sheraz Mian
Director of Research
Note: If you want an email notification each time Sheraz publishes a new article, pleaseclick here>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Stock Research Reports for Pfizer, Microsft & Bank of America
Wednesday, December 21 2016
Today's Research Daily features new research reports on 16 major stocks, including Pfizer (PFE - Free Report) , Microsoft (MSFT - Free Report) and Bank of America (BAC - Free Report) .
Pfizer shares have gained +9.5% since results of the presidential election were declared on Nov 8, outperforming the Zacks Large-Cap Pharma industry which has gained +1.7% over the same period. While Pfizer in general and the industry as a whole continues to be weighed down by drug pricing worries, the issue has eased a bit since the election. The analyst emphasizes that Pfizer is strengthening its product portfolio as well as pipeline through acquisitions and licensing deals. A case in point is the Sep 2016 acquisition of Medivation that has strengthened Pfizer’s cancer franchise. Meanwhile, new products like Ibrance should do well and drive revenues. However, headwinds remain in the form of genericization, pricing pressure and rising competition, which will continue to hamper top-line growth. (You can read the full research report on Pfizer here>>>)
Buy rated Microsoft shares lagged the Zacks Tech sector through the fall, but have led the way over the last three months on greater appreciation for the company's reorganization and repositioning. Microsoft's 'cloud' opportunity particularly stands out, with the company generally considered as a leader in this fast-growing space alongside Amazon, Google and others. The Zacks analyst points to the company's continuing enterprise strength, benefits from the Office 365 subscription model, strong growth prospects of Azure and promising new products. Further, the anticipated completion of the LinkedIn acquisition will boost Microsoft's presence in the social media market. (You can read the full research report on Microsoft here>>>)
Buy rated Bank of America shares have been one of the biggest beneficiaries of the changed macro backdrop following the election. This changed backdrop includes expectations of faster economic growth and overhaul of the country's tax and regulatory systems. The resulting uptrend in interest rates promises to give bank stocks in general and Bank of America in particular a big boost. No doubt, Bank of America share have been strong performers since the election - up +33.6% since November 8th vs. +21.8% gain for the Zacks Major Banks industry in that time period. (You can read the full research report on Bank of America here>>>)
Other noteworthy reports we are featuring today include Oracle (ORCL - Free Report) , Nike (NKE - Free Report) and Yahoo . You can see all of today's analyst reports here >>>
Free Access: All Zacks Research Reports
Starting today, you are invited to download in-depth analysis reports covering more than 1,000 of the most widely followed stocks. Valued at $25 each, they are yours to consult over the next 30 days absolutely free. They feature sensitive Zacks Rank information on each stock that you won't find anywhere else. See the reports free >>
Sheraz Mian
Director of Research
Note: If you want an email notification each time Sheraz publishes a new article, please click here>>>